New injection could shrink skin cancer before surgery
Disease control
Ongoing
This study tests an experimental drug called BO-112, injected directly into basal cell skin cancer tumors before they are surgically removed. The goal is to see if the drug can shrink or eliminate the cancer, and to check for side effects. About 60 adults with low- or high-risk b…
Phase: PHASE2 • Sponsor: Highlight Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC